Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The treatment of differentiated thyroid cancer (DCT) includes surgery followed by radioiodine
treatment. In the follow-up of patients it is necessary to induce TSH elevation to test for
cancer recurrence. One of the options is to stop L-thyroxin replacement for several weeks.
Current pilot study aims to induce the necessary TSH elevation by decreasing the L-thyroxin
dose. The main hypothesis is that necessary TSH stimulation will be achieved during 4-6 weeks
in majority of patients.